DSP Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
                                
                                ITI Pharma and Healthcare Fund Regular - Growth
                            
                                
                                DSP Healthcare Fund - Regular Plan - Growth
                            
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth | 
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth | 
| Investment Plan | Growth | Growth | 
| Level of Risk | Very High | Very High | 
| Asset Size (Cr) | ₹227 Cr | ₹3074 Cr | 
| Min Investment | ₹5000 | ₹100 | 
| Min SIP Invesment | ₹500 | ₹100 | 
| Min Addl Investment | ₹1000 | ₹100 | 
| Launch Date | 08 Nov 2021 | 30 Nov 2018 | 
| Category | Pharma & Healthcare | Pharma & Healthcare | 
| Fund Type | Open Ended | Open Ended | 
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare | 
| Turn Over | % | 18% | 
| Expense Ratio | 2.35 | 1.9 | 
| Manager | Rohan Korde | Jay Kothari | 
| ISIN Code | INF00XX01BL5 | INF740KA1LD8 | 
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | DSP Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 | 
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth | 
|---|---|---|
| 1 Month | 3.4% | 0.96% | 
| 6 Month | 4.39% | 5.85% | 
| 1 Year | -2.96% | -3.54% | 
| 3 Year | 18.57% | 21.65% | 
| 5 Year | - | 17.68% | 
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth | 
|---|---|---|
| 6 Month | 1.79% | 0.06% | 
| 1 Year | 4.26% | 0.78% | 
| 3 Year | 17.98% | 17.52% | 
| 5 Year | - | 16.88% | 
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth | 
|---|---|---|
| 1 Year | 18.94% | 25.18% | 
| 3 Year | 20.21% | 21.14% | 
| 5 Year | - | 26.06% | 
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth | 
|---|---|---|
| Standard Deviation | 15.64% | 14.63% | 
| Sharp | 0.77% | 0.98% | 
| Beta | 0.95% | 0.84% | 
| Alpha | -2.74% | 1.19% | 
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth | 
|---|---|---|
| Name | Rohan Korde | Jay Kothari | 
| Total AUM | ₹4626 Cr | ₹0 Cr | 
| Funds Managed | 10 | 20 | 
| ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth | 
Market Cap
| Scheme Name | 
                                                     ITI Pharma and Healthcare Fund Regular - Growth  | 
                                            
                                                
                                                     DSP Healthcare Fund - Regular Plan - Growth  | 
                                                                                    
                                    
|---|---|---|
| Others | 3.56 | 15.67 | 
| Large Cap | 29.45 | 16.72 | 
| Mid Cap | 37.33 | 14.23 | 
| Small Cap | 29.66 | 53.38 | 
Sector Allocation
| Scheme Name | 
                                                     ITI Pharma and Healthcare Fund Regular - Growth  | 
                                                                                            
                                                     DSP Healthcare Fund - Regular Plan - Growth  | 
                                                                                    
                                    
|---|---|---|
| Others | 1.52 | 2.73 | 
| Healthcare | 91.78 | 95.78 | 
| Basic Materials | 3.67 | - | 
| Industrials | 1.86 | - | 
| Financial Services | 1.17 | 1.48 | 
Top Comparisons
                                                
                                                INVESCO INDIA AGGRESSIVE HYBRID FUND - Regular Plan - Growth
                                            
3Y Returns15.94%
                                                
                                                 PGIM India Aggressive Hybrid Equity Fund - Growth Option
                                            
3Y Returns12.66%
                                                
                                                Franklin U.S. Opportunities Equity Active FOF - Regular - Growth
                                            
3Y Returns27.03%
                                                
                                                 HSBC Asia Pacific (Ex Japan) Dividend Yield Fund - Growth
                                            
3Y Returns24.23%
                                                
                                                Sundaram Equity Savings Fund (Formerly Known as Principal Equity Savings Fund) - Direct Plan - Growth Option
                                            
3Y Returns%
                                                
                                                 Sundaram Equity Savings Fund (Formerly Known as Principal Equity Savings Fund) - Direct Plan - Growth Option
                                            
3Y Returns%
                                                
                                                PGIM India Global Equity Opportunities Fund of Fund - Growth
                                            
3Y Returns25.79%
                                                
                                                 Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth
                                            
3Y Returns38.59%